Aims and scope
A major focus of the journal is on the immunologic processes leading to inflammation, damage and repair as they relate to autoimmune rheumatic and musculoskeletal conditions, and which inform the translation of this knowledge into advances in clinical care.
Original basic, translational and clinical research is considered for publication along with results of early and late phase therapeutic trials, especially as they pertain to the underpinning science that informs clinical observations in interventional studies.
Reflections of a rheumatologist
Synovitis in osteoarthritis: current understanding with therapeutic implications
In this review, Mathiessen and Conaghan review current knowledge on the prevalence of synovitis in osteoarthritis and its role in symptoms and structural progression, and explore lessons learnt from targeting synovitis therapeutically.
"Overall evidence suggests that synovial inflammation is associated with progressive joint failure at least in a subgroup of patients, and thus some osteoarthritis patients may benefit structurally from an anti-inflammatory intervention. "
Annual Journal Metrics
56 days to first decision for reviewed manuscripts only
48 days to first decision for all manuscripts
121 days from submission to acceptance
33 days from acceptance to publication
1,140 Altmetric Mentions